Ticker CXRXF – Advanz Pharma – sales, description, marketcap – Tickerday.com


Advanz Pharma

ADVANZ PHARMA Corp. is a multi-national pharmaceutical company headquartered in London. It changed its name from Concordia Healthcare Corp. in November 2018. The company focuses on a number of therapy areas including endocrinology, ophthalmology, urology, anti-infectives, pain management, central nervous system disorders, oncology, haematology, cardiology and intensive care medicine. The company also focuses on acquiring legacy pharmaceutical compounds which are usually off patent. ADVANZ PHARMA is a global pharmaceutical company with its operational headquarters in London, UK, operations centre in Mumbai, India and regional hubs in Europe, Australia and the US.

Index: OTC Markets; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 227.48M; Volume: 106.00; AvgVol 3m: 14.59K; Beta: 0.10;

Cost estimate:

P/E: ; EPS: -3.66; EPS growth quarter/prev quarter: ;

EPS growth this year: ; EPS growth past 5 years: ;

EPS ttm: ;

P/S: ; P/B: ; P/Cashflow: ; P/FCF: ;

Sales: 503.46M; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;


Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: ; Insider Transactions:;

Institutional Ownership: ; Institutional Transactions: ;

Data update: 07.10.2020.

Leave a comment

Your email address will not be published. Required fields are marked *